Patent · US Active

Extended release, abuse deterrent dosage forms

US12208094B2 · kind B2 · utility

0Cited by
6References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 16, 2022
Grant dateJan 28, 2025
Priority date
Expiry dateApr 18, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Extended release, abuse deterrent dosage forms comprising crush-resistant controlled-release particles that provide abuse deterrent properties to the dosage forms. The crush-resistant controlled-release particles, which comprise plastic/elastic polymers and at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, are prepared by a hot melt extrusion process.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.